Beyond BEST-CLI: In Search of A Reliable (? Wearable) Measure of Foot Perfusion

Speaker: Prof Matt Menard (Brigham and Women’s Hospital)

Short Bio: 

Dr. Matthew Menard graduated summa cum laude, phi beta kappa and with departmental high honors from Middlebury College. He attended Harvard Medical School and received his general surgery training at the Massachusetts General Hospital and vascular surgery fellowship training at the Brigham and Women’s Hospital.  He is currently Co-Director of Endovascular Surgery and the Vascular and Endovascular Surgery Fellowship Director at the Brigham and Women’s Hospital and is an Associate Professor of Surgery at Harvard Medical School. His clinical practice spans the gamut of vascular surgical disease, with a focus on chronic limb threatening ischemia (CLTI) and complex wound care.

Dr. Menard conceived and was a National Principal Investigator of the BEST-CLI Trial, an NIH-sponsored and FDA-endorsed randomized controlled trial comparing treatment efficacy, functional outcomes, cost and cost-effectiveness associated with open surgery vs endovascular therapy for patients with CLTI. The results were recently presented at the American Heart Association and published in the New England Journal of Medicine.